Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Wonsang Yu CEO | KRX SM Exchange | KR7000220004 ISIN |
KR Country | 253 Employees | - Last Dividend | 30 Mar 2021 Last Split | - IPO Date |
Yuyu Pharma, Inc., with a longstanding history since its inception in 1941, has positioned itself as a significant player in the pharmaceutical industry. Headquartered in Jecheon-si, South Korea, this esteemed enterprise specializes in the development and marketing of a wide spectrum of pharmaceutical products. Originally known as YuYu Inc., the company underwent a rebranding to Yuyu Pharma, Inc. in May 2008, marking a new chapter in its growth and evolution. Its dedication to healthcare is demonstrated through a diverse portfolio that encompasses prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, among others. Catering predominantly to neurology, endocrinology, and otolaryngology fields, Yuyu Pharma not only aims at improving patients' lives but also endeavors to contribute to the advancement of global health standards through innovation and excellence.